R K D Pharmaceutical LLP is a globally focused pharmaceutical export and healthcare sourcing company providing access to high-quality pharmaceutical formulations, APIs, excipients, nutraceuticals, medical devices, surgical consumables, laboratory ins...
- (+91) 9004316713
- ajay.sharma@rkdpharmaceutical.com
- Unit no.414, 4th Floor, Marathon Max, Mulund – Goregaon Link road, Mulund West, , Mumbai, Maharashtra, India. 400080
© 2020 R K D PHARMACEUTICAL LLP. All Rights Reserved
Lipid-Lowering Or Antihyperlipidemic
Atorvastatin Tablets 10 mg
Assay Purity & Pharmacopoeial Grade
Atorvastatin Tablets 10 mg identifies the active strength used in formulation and institutional stock lists. Content focuses on active identity and procurement suitability for manufacturers and hospital formulary procurement teams. Key buyer checks include assay confirmation and impurity limits in the batch COA.
Composition & Physicochemical Properties
The SKU represents the active ingredient at the stated strength. Buyers should confirm solubility, particle-size distribution, and any specified residual solvent limits to ensure compatibility with downstream excipient and processing steps.
Atorvastatin Tablets 20 mg
Assay Purity & Pharmacopoeial Grade
Atorvastatin Tablets 20 mg denotes the core active ingredient and strength used in lipid‑lowering formulations. The listing focuses on the active compound identity, assay expectations and procurement suitability for formulation and institutional buyers. Buyers evaluating this SKU will prioritise certificate-of-analysis (COA) traceability and batch assay data when assessing lots for downstream formulation.
Composition & Physicochemical Properties
The product is presented as the active pharmaceutical substance at the stated strength. Technical procurement should confirm assay, impurity profile and solubility compatibility with selected excipients. Typical evaluation covers assay %, residual solvents and packaging formats suitable for formulation and QC workflows.
